CHARLES SIDWA: Open Payments
NPI 1295784734 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,395 in 140 payments from 18 companies in 2025. Trend: 2023 $2,419 · 2024 $2,076 · 2025 $2,395
Food & beverage: $2,006Consulting: $250Education: $139
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $413 |
| LEO Pharma Inc. | 40 | $368 |
| Janssen Biotech, Inc. | 17 | $326 |
| ABBVIE INC. | 20 | $317 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $250 |
| Regeneron Healthcare Solutions, Inc. | 8 | $144 |
| PFIZER INC. | 7 | $125 |
| Lilly USA, LLC | 6 | $117 |
| Amgen Inc. | 4 | $73 |
| UCB, Inc. | 4 | $65 |
Products named: ADBRY, TREMFYA, SKYRIZI, Neo-Synalar, COSENTYX, DUPIXENT, CIBINQO, TALTZ.
Industry payments across NJ — which companies pay providers there.
